6/12 Drugs.com - Pharma News

Please add updates@feedmyinbox.com to your address book to make sure you receive these messages in the future. Drugs.com - Pharma News Commonwealth Biotechnologies, Inc. Provides Market Update on Contemplated Acquisition of GL Biochem June 11, 2009 at 3:10 pm RICHMOND, Va.--(BUSINESS WIRE)--Jun 11, 2009 - Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) is pleased to provide the following market update reporting on its recently executed term sheet to acquire all of the... TNS Media Intelligence Reports U.S. Advertising Expenditures Declined 14.2 Percent First Quarter 2009 June 11, 2009 at 12:22 pm NEW YORK, June 10, 2009 – Total measured advertising expenditures in the opening quarter of 2009 plunged 14.2 percent versus a year ago, to $30.18 billion, according to data released today by TNS Media Intelligence, the leading provider of... Neuromed Announces that Merck & Co., Inc. Terminates Research Collaboration and License Agreement for Compounds Targeting N-Type Calcium Channels June 11, 2009 at 11:42 am CONSHOHOCKEN, PA and VANCOUVER, BC, June 11 /PRNewswire/ -- Neuromed Pharmaceuticals Ltd. announced today that it has received notification that Merck & Co., Inc. will terminate the research collaboration and license agreement for novel... FTC Releases Report on ?Follow-on Biologic Drug Competition? June 11, 2009 at 10:17 am Providing FDA With Authority to Approve Follow-on Biologics Would be an Efficient Way to Bring Them to Market, Lowering Consumers’ Health Care Costs WASHINGTON, June 10, 2009--The Federal Trade Commission today released a report entitled... Xenon Enters Cardiovascular Disease Collaboration With Merck & Co., Inc. June 11, 2009 at 8:06 am VANCOUVER, Canada, June 11 /PRNewswire/ -- Xenon today announced a strategic alliance with Merck & Co., Inc., through an affiliate, to discover and develop novel small molecule candidates for the potential treatment of cardiovascular...   This email was sent to skripayura.drugsnews@blogger.com.  Create Your Account Don't want to receive this feed any longer? Unsubscribe here.